CNR1 and fatty liver disease: Previous studies have shown that elevated levels of 2-AG, the main CB1 endogenous agonist, increase the transcription of lipogenic genes and increase TG production in the liver, thus contributing to the development of diet-induced fatty liver [34,35,36].